Target Validation Information
Target ID T40696
Target Name Topoisomerase IV
Target Type
Successful
Drug Potency against Target Gatifloxacin Drug Info IC50 = 13800 ng/mL [538128]
Sparfloxacin Drug Info IC50 = 19100 ng/mL [552295]
References
Ref 538128Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases. Antimicrob Agents Chemother. 1998 Oct;42(10):2678-81.
Ref 552295Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV of Enterococcus faecalis. Antimicrob Agents Chemother. 2002 Jun;46(6):1800-4.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.